| 9670270 |
Minicell based delivery of biologically active compounds |
Neil Berkley, Mark William Surber, Robert Klepper |
2017-06-06 |
|
| 9274129 |
Methods and reagents for detecting bioactive lipids |
William A. Garland, Genevieve Hansen |
2016-03-01 |
$82,000 |
| 9274130 |
Prevention and treatment of pain using antibodies to lysophosphatidic acid |
Rosalia MATTEO |
2016-03-01 |
$82,000 |
| 9217749 |
Immune-derived moieties reactive against lysophosphatidic acid |
William A. Garland, Genevieve Hansen |
2015-12-22 |
$192,000 |
| 9181331 |
Pharmaceutical compositions for binding sphingosine-1-phosphate |
Scott R. Pancoast, Genevieve Hansen, William A. Garland, Marina Yu SAFONOV |
2015-11-10 |
$171,000 |
| 9163091 |
Compositions and methods for binding lysophosphatidic acid |
William A. Garland, Genevieve Hansen, James Stephen SWANEY, Rosalia MATTEO, Gordon MILLS +1 more |
2015-10-20 |
$170,000 |
| 9017986 |
Minicell based delivery of biologically active compounds |
Neil Berkley, Mark William Surber, Robert Klepper |
2015-04-28 |
|
| 8871202 |
Prevention and treatment of pain using antibodies to sphingosine-1-phosphate |
— |
2014-10-28 |
$276,000 |
| 8796429 |
Bioactive lipid derivatives, and methods of making and using same |
William A. Garland, Genevieve Hansen |
2014-08-05 |
$595,000 |
| 8614103 |
Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions |
William A. Garland, Glenn L. Stoller |
2013-12-24 |
$611,000 |
| 8604172 |
Humanized antibody compositions and methods for binding lysophosphatidic acid |
William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams |
2013-12-10 |
$651,000 |
| 8524484 |
Immunogenic minicells and methods of use |
Neil Berkley, Mark William Surber, Matthew J. Giacalone |
2013-09-03 |
|
| 8444970 |
Compositions and methods for treating ocular diseases and conditions |
William A. Garland, Glenn L. Stoller |
2013-05-21 |
$748,000 |
| 8401799 |
Antibody design using anti-lipid antibody crystal structures |
Tom HUXFORD, Jonathan Michael WOJCIAK |
2013-03-19 |
$677,000 |
| 8361465 |
Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents |
William A. Garland |
2013-01-29 |
$865,000 |
| 8222373 |
Humanized antibodies and compositions for binding sphingosine-1-phosphate |
William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams |
2012-07-17 |
|
| 8158124 |
Compositions and methods for binding lysophosphatidic acid |
William A. Garland, Genevieve Hansen, James Stephen SWANEY |
2012-04-17 |
|
| 8129166 |
Immunogenic minicells and methods of use |
Neil Berkley, Mark William Surber |
2012-03-06 |
|
| 8101396 |
Minicells displaying antibodies or derivatives thereof and comprising biologically active compounds |
Neil Berkley, Mark William Surber, Robert Klepper |
2012-01-24 |
|
| 8067549 |
Humanized antibodies and compositions for binding sphingosine-1-phosphate |
William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams |
2011-11-29 |
|
| 8025877 |
Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate |
William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams |
2011-09-27 |
|
| 8026342 |
Compositions and methods for binding sphingosine-1-phosphate |
William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams |
2011-09-27 |
|
| 7956173 |
Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate |
William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams |
2011-06-07 |
|
| 7901682 |
Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation |
— |
2011-03-08 |
|
| 7871815 |
Rhamnose-inducible expression constructs and methods |
Neil Berkley, Mark William Surber |
2011-01-18 |
|